Skip to main content

Psychae Therapeutics

This startup develops pharmaceutical-grade DMT-based medicines and therapies aimed at treating severe mental illnesses through a tailored psychological treatment model. Utilizing a proprietary extraction technique, the company ensures the standardization of active ingredients at pharmaceutical purity levels, enhancing patient quality of life.

Traction 5/10
Carlton, Australia · HQ
Founded 20224200+ followers
  • Biotechnology
Updated 6 months ago

Funding

Raised to date

$4.5MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

2 founders

Daniel Perkins

CEO

Jerome Sarris

Chief Scientific Officer

Product

Features

  • This startup develops pharmaceutical-grade DMT-based medicines and therapies aimed at treating severe mental illnesses through a tailored psychological treatment model. Utilizing a proprietary extraction technique, the company ensures the standardization of active ingredients at pharmaceutical purity levels, enhancing patient quality of life.
This profile is AI-generated and may contain inaccuracies.